http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2422665-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_558522fabc21189ae622f703f61fb846 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08 |
filingDate | 1978-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1979-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | FR-2422665-A1 |
titleOfInvention | PROCESS FOR PREPARING RIFAMYCINS, NEW COMPOUNDS OBTAINED AND THEIR THERAPEUTIC APPLICATION |
abstract | The present invention relates to a process for the preparation of rifampicin, characterized in that rifamycin S is reacted in a dipolar aprotic solvent, with a hexahydro-1,3,5-triazine trisubstituted in positions 1,3,5 , at a temperature of 20 to 100 degrees C, then reacting with 1-amino-4-methylpiperazine while maintaining the pH in the range of 5 to 7, and finally isolating the rifampicin formed This process also allows d 'to obtain new rifamycin derivatives with antibiotic activity. |
priorityDate | 1977-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.